Table 2.
Association of serum lp(a) concentrations with risk of renal function damage.
| Model 1 | Model 2 | ||||
|---|---|---|---|---|---|
| Cases, N (%) | OR (95%CI) | P | OR (95%CI) | P | |
| Continuous | |||||
| lp (a) | 4012 (15.8) | 1.006 (1.004, 1.007) | <0.001 | 1.006 (1.004, 1.008) | <0.001 |
| Categorical | |||||
| <25% | 776 (12.3) | Ref. | – | Ref. | – |
| 25 to <50% | 970 (15.3) | 1.250 (1.116, 1,399) | <0.001 | 1.235 (1.095, 1.390) | 0.001 |
| 50 to <75% | 1093 (17.2) | 1.459 (1.305, 1.631) | <0.001 | 1.416 (1.259 1.594) | <0.001 |
| 75 to <90% | 688 (18.1) | 1.474 (1.299, 1.672) | <0.001 | 1.463 (1.280, 1.672) | <0.001 |
| 90 to <95% | 226 (17.8) | 1.511 (1.256, 1.819) | <0.001 | 1.472 (1.211, 1.788) | <0.001 |
| ≥95% | 259 (20.4) | 1.664 (1.390, 1.991) | <0.001 | 1.603 (1.325, 1.938) | <0.001 |
| P for trend | <0.001 | <0.001 | |||
Model 1 was adjusted for age, gender, area, education, and BMI.
Model 2 was adjusted for age, gender, region, BMI, HDL-C, LDL-C, TG, TC, current smoking status, alcohol taking, exercise, education status, hypertension, diabetes mellitus, BUN, UA, CRPHS.